Exited position

Renaissance Technologies LLC’s Hca Healthcare Inc (HCA) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Renaissance Technologies LLCVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ3 2013Earliest verified positive filing snapshot
Latest statusExited positionBased on the latest supported relationship state
Peak shares1.09MHighest verified quarter-end share count
Quarters reported25Verified quarters with shares above zero
What happened?

Renaissance Technologies LLC first reported Hca Healthcare Inc in Q3 2013. The reported position was increased and reduced across later filings. The latest verified relationship event shows that Renaissance Technologies LLC sold the entire position in Q3 2022, and the stock is no longer reported in the latest verified portfolio.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q3 2022
Sold the entire position−323.51K shares · No shares reported at quarter-end
Q2 2022
Bought 199.5% more+215.51K shares · 323.51K shares reported after the change
Filing context

Quarter-end price $168.06

Q1 2022
Sold 66.0% of the position−209.40K shares · 108.00K shares remained
Filing context

Quarter-end price $250.62

Q4 2021
New position+317.40K shares · 317.40K shares reported
Filing context

Quarter-end price $256.92

Q3 2020
Sold the entire position−977.40K shares · No shares reported at quarter-end
Q2 2020
Bought 77.7% more+427.50K shares · 977.40K shares reported after the change
Filing context

Quarter-end price $97.06

Portfolio importance

How important was Hca Healthcare Inc in Renaissance Technologies LLC’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.1%Q2 2022
Last reported rank#340Rank unavailable
Peak portfolio weight0.1%Q2 2018
Best historical rank#168Q2 2018
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$438.122026-09-22

Market context only; not an investor transaction price.

Latest verified investor filingQ2 2026 · filed 2026-08-13
Open SEC filing ↗

Coverage is bounded to the institution’s top reported positions and material events rather than every security in each Form 13F. The filing reflects reportable U.S.-listed holdings, not Renaissance’s secret models, complete trading book, exact trade dates or execution prices.